NasdaqGM - Delayed Quote USD

ProShares UltraPro Nasdaq Biotechnology (UBIO)

17.77 0.00 (0.00%)
At close: March 27 at 3:59 PM EDT

Top 10 Holdings (241.96% of Total Assets)

SymbolCompany% Assets
75.41%
52.94%
38.60%
31.75%
11.72%
GILD
Gilead Sciences, Inc. 7.77%
VRTX
Vertex Pharmaceuticals Incorporated 6.52%
AMGN
Amgen Inc. 6.41%
BIIB
Biogen Inc. 6.30%
REGN
Regeneron Pharmaceuticals, Inc. 4.54%

Sector Weightings

SectorUBIO
Healthcare   99.96%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 32.42%
Bonds 0.00%

Equity Holdings

Price/Earnings 18.16
Price/Book 4.62
Price/Sales 4.51
Price/Cashflow 14.29
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA 0.00%
AA 0.00%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
Other 0.00%

ETF Summary

The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index® (the "index"). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

ETF Overview

Category Trading--Leveraged Equity
Fund Family ProShares
Net Assets 15.09M
YTD Daily Total Return -45.70%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers